Ma Kun, Shao Zefeng, Xu Xiangxian, Guo Shanfeng, Wang Youjin, Wang Zhongqiu
Department of Interventional Medicine, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Department of Radiology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
J Gastrointest Oncol. 2022 Oct;13(5):2415-2425. doi: 10.21037/jgo-22-940.
This study aimed to determine the role of LINC00178 in colorectal cancer (CRC) cell invasion and migration by examining its expression in CRC cells and tissues.
Cancer tissues and corresponding adjacent tissue specimens were collected from 45 patients who experienced radical CRC resection in the hospital from March to September 2021. The expression of LINC00178 was measured in both CRC cells and tissues and normal human colorectal mucosal cells using quantitative fluorescence polymerase chain reaction (QF-PCR). Cell Counting Kit-8 (CCK-8), clonogenic, and transwell assays were used to assess the impact of LINC00178 overexpression or knockdown on the CRC cells invasion and proliferation. In addition, the expression levels of vimentin, E-cadherin, and N-cadherin in CRC cells were determined after either LINC00178 knockdown or overexpression was performed using western blotting.
The experiments revealed that LINC00178 was over expressed in CRC cells and tissues. Over-expression of LINC00178 could significantly promote the propagation, clone formation, invasion, and transportation of CRC, whereas knockdown of LINC00178 had the opposite function. When LINC00178 was expressed at high levels, it suppressed the vimentin and N-cadherin expression and prevented the upregulation of E-cadherin. (nude mouse) studies showed that the over expression of LINC00178 could significantly promote the propagation in CRC cells.
LINC00178 is overexpressed in CRC cells and tissues. and experiments showed that LINC00178 can significantly promote the propagation of CRC cells, so it may develop a potential biological site for targeted therapy of CRC patients.
本研究旨在通过检测LINC00178在结直肠癌(CRC)细胞和组织中的表达,确定其在CRC细胞侵袭和迁移中的作用。
收集2021年3月至9月在本院接受根治性CRC切除术的45例患者的癌组织及相应的癌旁组织标本。采用定量荧光聚合酶链反应(QF-PCR)检测CRC细胞、组织及正常人结肠黏膜细胞中LINC00178的表达。使用细胞计数试剂盒-8(CCK-8)、克隆形成实验和Transwell实验评估LINC00178过表达或敲低对CRC细胞侵袭和增殖的影响。此外,在对LINC00178进行敲低或过表达后,采用蛋白质免疫印迹法检测CRC细胞中波形蛋白、E-钙黏蛋白和N-钙黏蛋白的表达水平。
实验显示LINC00178在CRC细胞和组织中高表达。LINC00178的过表达可显著促进CRC的增殖、克隆形成、侵袭和转移,而LINC00178的敲低则具有相反作用。当LINC00178高表达时,可抑制波形蛋白和N-钙黏蛋白的表达,并阻止E-钙黏蛋白的上调。(裸鼠)实验表明LINC00178的过表达可显著促进CRC细胞的增殖。
LINC00178在CRC细胞和组织中过表达。体内和体外实验表明LINC00178可显著促进CRC细胞的增殖,因此它可能成为CRC患者靶向治疗的潜在生物学靶点。